|
PDCL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.802300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.377600E-02 |
| Normal-vs-Stage2 |
5.652000E-02 |
| Normal-vs-Stage3 |
1.611040E-01 |
| Normal-vs-Stage4 |
8.079200E-01 |
| Stage1-vs-Stage2 |
5.778000E-01 |
| Stage1-vs-Stage3 |
8.753600E-01 |
| Stage1-vs-Stage4 |
1.205370E-01 |
| Stage2-vs-Stage3 |
5.761800E-01 |
| Stage2-vs-Stage4 |
8.876400E-02 |
| Stage3-vs-Stage4 |
1.814220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.044850E-01 |
| Normal-vs-AfricanAmerican |
1.376830E-01 |
| Normal-vs-Asian |
8.447600E-01 |
| Caucasian-vs-AfricanAmerican |
6.353400E-01 |
| Caucasian-vs-Asian |
5.082800E-01 |
| AfricanAmerican-vs-Asian |
4.319800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.496300E-02 |
| Normal-vs-Female |
9.959400E-01 |
| Male-vs-Female |
2.404200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.363830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.374950E-01 |
| Normal-vs-Age(61-80Yrs) |
2.819600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.146300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.506400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.829600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.836200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.665230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.081220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.597800E-01 |
| Normal-vs-Grade 2 |
7.483800E-02 |
| Normal-vs-Grade 3 |
1.217980E-01 |
| Normal-vs-Grade 4 |
8.651400E-01 |
| Grade 1-vs-Grade 2 |
7.607000E-01 |
| Grade 1-vs-Grade 3 |
7.688000E-01 |
| Grade 1-vs-Grade 4 |
8.467800E-01 |
| Grade 2-vs-Grade 3 |
8.608000E-01 |
| Grade 2-vs-Grade 4 |
2.830800E-01 |
| Grade 3-vs-Grade 4 |
3.471800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.896200E-01 |
| Normal-vs-ccB subtype |
4.855500E-02 |
| ccA subtype-vs-ccB subtype |
1.706850E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.625800E-02 |
| Normal-vs-N1 |
5.128600E-01 |
| N0-vs-N1 |
6.882800E-01 |
|
|
